Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Epithelial cell of renal tubule

Known as: cell kidney, Renal Cell, cells kidneys 
A glandular epithelial cell found in the kidney.
National Institutes of Health

Related topics

Related topics

5 relations
EpitheliumRenal Tissue

Broader (1)

Kidney

Narrower (2)

Mesangial Cells, KidneyPodocytes

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
EAU guidelines on renal cell carcinoma: 2014 update.
CONTEXT The European Association of Urology Guideline Panel for Renal Cell Carcinoma (RCC) has prepared evidence-based guidelines… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Highly Cited
2010
Highly Cited
2010
Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates.
PURPOSE Programmed death-1 (PD-1), an inhibitory receptor expressed on activated T cells, may suppress antitumor immunity. This… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Review
2010
Review
2010
Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial.
PURPOSE Pazopanib is an oral angiogenesis inhibitor targeting vascular endothelial growth factor receptor, platelet-derived… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Highly Cited
2009
Highly Cited
2009
Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma.
PURPOSE A randomized, phase III trial demonstrated superiority of sunitinib over interferon alfa (IFN-alpha) in progression-free… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Review
2008
Review
2008
Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
BACKGROUND Everolimus (RAD001) is an orally administered inhibitor of the mammalian target of rapamycin (mTOR), a therapeutic… Expand
Highly Cited
2008
Highly Cited
2008
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
BACKGROUND Vascular endothelial growth factor (VEGF) inhibition is a valid therapeutic approach in renal cell carcinoma… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Review
2005
Review
2005
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
Five years after the last prostatic carcinoma grading consensus conference of the International Society of Urological Pathology… Expand
Highly Cited
2002
Highly Cited
2002
Prognostic Impact of Histologic Subtyping of Adult Renal Epithelial Neoplasms: An Experience of 405 Cases
Just two and a half decades ago adult renal cell neoplasms, i.e., those arising from the renal tubules or collecting duct… Expand
Highly Cited
1993
Highly Cited
1993
Identification of the von Hippel-Lindau disease tumor suppressor gene.
A gene discovered by positional cloning has been identified as the von Hippel-Lindau (VHL) disease tumor suppressor gene. A… Expand
Highly Cited
1982
Highly Cited
1982
Prognostic significance of morphologic parameters in renal cell carcinoma
The prognostic significance of morphologic parameters was evaluated in 103 patients with renal cell carcinoma diagnosed during… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE